GAMT facilitates tumor progression via inhibiting p53 in clear cell renal cell carcinoma

GAMT facilitates tumor progression via inhibiting p53 in clear cell renal cell carcinoma

Abstract Background Clear cell renal cell carcinoma (ccRCC) is the most common type of RCC. Even though the targeted drugs for the treatment of ccRCC have a certain therapeutic effect, due to the problem of drug resistance, the search for new targets for targeted therapy of ccRCC remains urgent. GAM...

Full description

Saved in:
Bibliographic Details
Main Authors: Bin Zheng, Kan Liu, Ji Feng, Qing Ouyang, Tongyu Jia, Yaohui Wang, Shuo Tian, Xinran Chen, Tianwei Cai, Lequan Wen, Xu Zhang, Xiubin Li, Xin Ma
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Biology Direct
Subjects:
Clear cell renal cell carcinoma
GAMT
Fisetin
p53
Online Access:https://doi.org/10.1186/s13062-025-00641-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13062-025-00641-y

Similar Items